Breaking
Saturday, June 20, 2026

FDA News

🇺🇸 FDA Page 32

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 373–384 of 391 articles

High impact NewsApr 11, 2026

FDA Approves Higher-Dose Wegovy 7.2mg for Weight Loss Under Priority Review Program

FDA · obesity/weight management · 3 min

Dr. Sarah Mitchell
Critical impact NewsApr 11, 2026

FDA Approves First Treatment for Neurologic Symptoms of Hunter Syndrome

FDA · 2 min

Dr. Sarah Mitchell
High impact NewsApr 11, 2026

FDA Approves Kresladi: First Gene Therapy for Rare Immune Disorder LAD-I Marks Medical Breakthrough

FDA · Rare genetic immunodeficiency disorders · 3 min

Dr. Sarah Mitchell
High impact NewsApr 11, 2026

FDA Approves Foundayo's Orforglipron as First New Molecular Entity Under Priority Voucher Program

FDA · 2 min

Dr. Sarah Mitchell
High impact NewsApr 11, 2026

FDA Approves CogniMax: New Early-Stage Alzheimer's Treatment

FDA · Alzheimer's disease · 7 min

Dr. Sarah Mitchell
Standard impact AnalysisApr 10, 2026

AI in FDA Drug Approvals: What You Need to Know

FDA · Pharmaceutical development · 10 min

Dr. Sarah Mitchell
High impact NewsApr 9, 2026

FDA Approves Repatha: Key Details on Amgen's Cardiovascular Drug

FDA · Cardiovascular Disease · 4 min

Dr. Sarah Mitchell
High impact NewsApr 9, 2026

FDA Approves Tecentriq for Extensive-Stage Small Cell Lung Cancer

FDA · oncology · 4 min

Dr. Sarah Mitchell
High impact NewsApr 5, 2026

FDA Approves Altuviiio: Sanofi's Long-Acting Hemophilia A Therapy

FDA · Hemophilia A · 4 min

Dr. Sarah Mitchell
High impact NewsApr 5, 2026

FDA Approves Litfulo: Key Facts on Pfizer’s Alopecia Treatment

FDA · alopecia areata · 4 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Approves First OTC Naloxone Nasal Spray for Opioid Overdose

FDA · Opioid Overdose Treatment · 5 min

Dr. Sarah Mitchell
High impact NewsApr 4, 2026

FDA Grants Priority Review to Sotorasib for KRAS G12C NSCLC

FDA · non-small cell lung cancer · 4 min

Dr. Sarah Mitchell